Clene Inc logo

CLNN

Clene Inc

$3.69

Earnings Summary

Revenue
$0Mn
Net Profits
$-0Mn
Net Profit Margins
-44500%
PE Ratio
11.71

Highlights

Revenue:

Clene Inc’s revenue fell -100% since last year same period to $0Mn in the Q1 2022. On a quarterly growth basis, Clene Inc has generated 100% jump in its revenue since last 3-months.

Net Profits:

Clene Inc’s net profit jumped 100% since last year same period to $-0Mn in the Q1 2022. On a quarterly growth basis, Clene Inc has generated -100% fall in its net profits since last 3-months.

Net Profit Margins:

Clene Inc’s net profit margin fell -138.42% since last year same period to -44500% in the Q1 2022. On a quarterly growth basis, Clene Inc has generated -1026.84% fall in its net profit margins since last 3-months.

PE Ratio:

Clene Inc’s price-to-earnings ratio after this Q1 2022 earnings stands at 11.71.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Clene Inc post its latest quarter earnings

EPS Estimate Current Quarter
-0.2
EPS Estimate Current Year
-0.2

Highlights

EPS Estimate Current Quarter:

Clene Inc’s earning per share (EPS) estimates for the current quarter stand at -0.2 - a -5.26% fall from last quarter’s estimates.

EPS Estimate Current Year:

Clene Inc’s earning per share (EPS) estimates for the current year stand at -0.2.

Key Ratios

Key ratios of the Clene Inc post its Q1 2022 earnings

Earning Per Share (EPS)
-0.21
Return on Assets (ROA)
-0.55
Return on Equity (ROE)
-1.51
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

Clene Inc’s earning per share (EPS) jumped 68.18% since last year same period to -0.21 in the Q1 2022. This indicates that the Clene Inc has generated 68.18% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Clene Inc’s return on assets (ROA) stands at -0.55.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Clene Inc’s return on equity (ROE) stands at -1.51.

Dividend Per Share (DPS):

Clene Inc declared 0 dividend per share during the earnings announcement for Q1 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-05-09
-0.19
-0.21
-10.53%

Company Information

Clene is a clinical-stage biopharmaceutical company focused on the development of unique therapeutics for neurodegenerative diseases. Clene has innovated a novel nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. Clene has also advanced into the clinic an aqueous solution of ionic zinc and silver for anti-viral and anti-microbial uses. Founded in 2013, the company is based in Salt Lake City, Utah with R&D and manufacturing operations located in North East, Maryland.

Organisation
Clene Inc
Employees
2.02K